It is better for your health to begin HIV treatment sooner, rather than later. There are some fixed-dose pills that combine two or three antiretroviral drugs from more than one drug class. These allow ...

A groundbreaking annual injection designed to protect against Human Immunodeficiency Virus (HIV) has successfully ...

The combination of tenofovir, FTC, and efavirenz might soon be available in a single pill. For years, effective antiretroviral treatment has required HIV-positive patients to take a large handful ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

The FDA just approved a new combination of drugs to treat HIV. The treatment combines three drugs into one daily pill: bictegravir, emtricitabine and tenofovir alafenamide. The new approval could ...

A new study by UCSF researchers reveals that long-acting injectable treatments offer a promising alternative for HIV patients who find it challenging to adhere to daily pill regimens. This ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers at UCSF has found. The strategy could also help stop the spread of HIV ...

Advances in care over the last 30 years have helped transform HIV from a fatal disease into ... with three medications combined into one pill, and many subsequent improvements in STRs combining ...

The triple-combination of bictegravir, emtricitabine, and tenofovir alafenamide is a one-a-day pill to treat patients with HIV-1.

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers at UCSF has found. The strategy could also help stop the spread of HIV ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found. UCSF researchers are the first to demonstrate that the approach works for ...